Glioblasztóma: vizsgálatok itt: Ausztrália
19 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors
- Where
- Bedford Park, Kogarah
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Eilean Therapeutics
See details and how to joinNCT07524140 - 2/3. fázisTaking peopleA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Where
- Bedford Park, Heidelberg, Herston, Melbourne, St Leonards, Waratah
- Életkor
- 18 év and over
- People
- 2250 worldwide
- Run by
- Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00 - Korai 1. fázisNot yet taking people in AusztráliaBiomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
- Where
- Heidelberg
- Életkor
- 18 év to 55 év
- People
- 12
- Run by
- Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07908147 - 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Camperdown, Concord, Epping, Waratah
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - 1. fázisNot yet taking people in AusztráliaOLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
- Where
- Brisbane, Heidelberg, Herston, Melbourne, Sydney
- Életkor
- 18 év to 75 év
- People
- 54
- Run by
- Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07739017 - 3. fázisTaking peopleSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Where
- Darlinghurst, Herston, Melbourne, Nedlands, Saint Leonards
- Életkor
- 18 év and over
- People
- 365 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT05303519 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Nedlands, Randwick, South Brisbane, Westmead
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 2. fázisTaking peopleTrial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
- Where
- Parkville
- Életkor
- 18 év and over
- People
- 92 worldwide
- Run by
- Duke University
See details and how to joinNCT06816927 - 1. fázisTaking peopleImmunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
- Where
- Liverpool, Randwick
- Életkor
- 18 év to 100 év
- People
- 26
- Run by
- Charlotte Lemech
See details and how to joinNCT06132438 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Melbourne, Perth, Randwick, South Brisbane
- Életkor
- 12 hónap to 39 év
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - 2. fázisTaking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Perth, Randwick, South Brisbane
- Életkor
- 12 év to 39 év
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - No phaseTaking peopleThe Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
- Where
- Saint Leonards
- Életkor
- 18 év and over
- People
- 20
- Run by
- Royal North Shore Hospital
See details and how to joinNCT07052877 - 3. fázisTaking peopleStudy of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
- Where
- Adelaide, Gold Coast, Melbourne, Perth
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Telix Pharmaceuticals (Innovations) Pty Limited
See details and how to joinNCT07100730 - Korai 1. fázisNot yet taking people in AusztráliaPilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 12
- Run by
- Olivia Newton-John Cancer Research Institute
See details and how to joinNCT07712770 - Korai 1. fázisTaking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Perth, Randwick, South Brisbane
- Életkor
- 1 év to 21 év
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - 2. fázisTaking peopleStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Melbourne, Perth, Randwick, South Brisbane
- Életkor
- 12 hónap to 39 év
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - No phaseTaking peopleMRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
- Where
- St Leonards
- Életkor
- 18 év and over
- People
- 20
- Run by
- University of Sydney
See details and how to joinNCT05500612 - 1/2. fázisTaking peopleEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
- Where
- Kogarah, Liverpool, Miranda
- Életkor
- 18 év and over
- People
- 80
- Run by
- Filamon LTD
See details and how to joinNCT06926075 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00